An observational study in Abdominal Aortic Aneurysm and Aorto-iliac Aneurysm, sponsored by Cook Group Incorporated. Terminated at 15 sites in 7 countries. Per ClinicalTrials.gov, last updated 2012-10-11.
Sponsored by Cook Group Incorporated · Observational
A registry to collect additional prospective intra-operative and follow-up information on physician use of the CE-marked Zenith® Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft under routine clinical care.
960 studies on the registry are indexed under Aneurysm; 175 are open to participants now.
This study's enrollment of 76 is below the median of 151 across 443 observational studies indexed under Aneurysm.
Browse Aneurysm studies →Cook Group Incorporated is the lead sponsor of 73 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients implanted with a CE-Marked Zenith® Low Profile AAA Endovascular Graft
Exclusion Criteria:
Device: Zenith® Low Profile AAA Endovascular Graft
Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.
graft patency and aneurysm exclusion
Time frame: during (day 1) and after implantation through 12 months
This study is terminated, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cook Group Incorporated